A cold-shooting night for Oregon Tech came at the wrong time of the season, as No. 3-ranked Arizona Christian held the ...
A service disruption on campus brought down many University services and applications for much of Thursday, though the issue ...
On Tuesday, March 25, the Office of Information Technology will upgrade the GlobalProtect VPN client.
A clinical trial has found that the medication omalizumab, marketed as Xolair, treated multi-food allergy more effectively than oral immunotherapy (OIT) in people with allergic reactions to very small ...
Clinical trial shows omalizumab (Xolair) treats multiple severe food allergies more effectively than oral immunotherapy, with ...
13d
MedPage Today on MSNOmalizumab Superior to Oral Immunotherapy for Kids With Multi-Food AllergyOmalizumab (Xolair) injections outperformed oral immunotherapy (OIT) in increasing tolerance among children with multi-food ...
Omalizumab was found to be more effective than multi-allergen oral immunotherapy (OIT) in reducing allergic reactions in patients with 1 or more food allergies, according to results from Stage 2 of ...
OIT to discontinue support for phone and SMS multi-factor authentication, require Duo or Duke Unlock
For community members who currently rely on SMS messages or phone calls for multi-factor authentication (MFA), OIT instructs ...
The study suggests that omalizumab could become a safer, more effective alternative to OIT for people with highly sensitive ...
The high rate of side effects from oral immunotherapy in the NIH trial explains the superiority of omalizumab. A clinical ...
Patrick Barry extended his record hitting streak to 36 games, combining for four hits on the day, as Oregon Tech split a ...
News Medical on MSN14d
Omalizumab treats multi-food allergy better than oral immunotherapyThe high rate of allergic reactions and other intolerable side effects of oral immunotherapy in the NIH-funded trial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results